Home > Insider Trading > Filing (0001104659-20-094674)

Filing Details

Accession Number:: 0001104659-20-094674
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2020-08-13 16:11:25
Reporting Period:: 2020-05-15

Accepted Time:: 2020-08-13 16:11:25
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1104506	Insmed Inc	INSM	Pharmaceutical Preparations (2834)	541972729

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1401017	Nicole S Orlov Schaeffer	700 Us Highway 202/206 Bridgewater NJ 08807	Chief People Strategy Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2020-05-15	1,126	$25.46	35,227	No	4	F	Direct
Common Stock	Acquisiton	2020-08-11	3,761	$6.96	38,988	No	4	M	Direct
Common Stock	Disposition	2020-08-11	3,761	$30.07	35,227	No	4	S	Direct
Common Stock	Acquisiton	2020-08-12	465	$6.96	35,692	No	4	M	Direct
Common Stock	Disposition	2020-08-12	465	$28.77	35,227	No	4	S	Direct
Common Stock	Acquisiton	2020-08-12	4,000	$12.44	39,227	No	4	M	Direct
Common Stock	Disposition	2020-08-12	4,000	$28.80	35,227	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	F	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (right to buy)	Disposition	2020-08-11	3,761	$0.00	3,761	$6.96
Common Stock	Stock Option (right to buy)	Disposition	2020-08-12	465	$0.00	465	$6.96
Common Stock	Stock Option (right to buy)	Disposition	2020-08-12	4,000	$0.00	4,000	$12.44

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
465	2023-01-02	No	4	M	Direct
0	2023-01-02	No	4	M	Direct
8,500	2023-05-23	No	4	M	Direct

Footnotes

Represents the withholding of shares of common stock to satisfy tax withholding obligations in connection with the vesting of restricted stock units. This transaction was not reported previously due to a clerical error.
This is the weighted average sales price representing 3,761 shares sold at prices ranging from $30.00 to $30.45 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
This is the weighted average sales price representing 465 shares sold at prices ranging from $28.75 to $28.79 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
This is the weighted average sales price representing 4,000 shares sold at prices ranging from $28.71 to $28.95 per share. The number sold at each price will be made available to the SEC staff, the issuer, or a security holder of the issuer upon request.
The options become exercisable based on the following vesting schedule: twenty five percent (25%) vest on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vest on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.
On May 23, 2013, the reporting person was granted an option to purchase 25,000 shares of common stock. The option vests in two installments based upon the Issuer's satisfaction of two separate performance metrics. The first installment vested on February 26, 2015. The performance metric applicable to the second installment, the first written approval of a New Drug Application or Marketing Authorization Application from the Food and Drug Administration of European Medicines Agency, respectively, was met on September 28, 2018, resulting in the vesting of the second installment.